We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

126 hedge funds and large institutions have $171M invested in VanEck Biotech ETF in 2021 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 29 increasing their positions, 33 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 12

7% more funds holding

Funds holding: 118 → 126 (+8)

5% more capital invested

Capital invested by funds: $163M → $171M (+$8.32M)

2.41% more ownership

Funds ownership: 28.03% → 30.44% (+2.4%)

12% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 33

68% less call options, than puts

Call options by funds: $627K | Put options by funds: $1.95M

Holders
126
Holders Change
+8
Holders Change %
+6.78%
% of All Funds
1.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
29
Reduced
33
Closed
12
Calls
$627K
Puts
$1.95M
Net Calls
-$1.32M
Net Calls Change
-$862K

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$17M
2
Morgan Stanley
Morgan Stanley
New York
+$3.63M
3
Chevy Chase Trust
Chevy Chase Trust
Maryland
+$2.65M
4
CCA
Conservest Capital Advisors
Pennsylvania
+$1.41M
5
CIBC Private Wealth Group
CIBC Private Wealth Group
Georgia
+$1.25M

Top Sellers

Rank Fund Capital Flow
1
Stifel Financial
Stifel Financial
Missouri
-$2.49M
2
FTUS
Flow Traders U.S.
New York
-$2.22M
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$1.8M
4
SBH
Segall Bryant & Hamill
Illinois
-$1.04M
5
KWM
Kingsview Wealth Management
Oregon
-$1M
Name Holding Trade Value Shares
Change 		Change in
Stake
EDRH
101
Edmond de Rothschild Holding
Switzerland
$25K -$270K -1,400 -92%
Fidelity Investments
102
Fidelity Investments
Massachusetts
$23K +$771 +4 +3%
Carson Wealth (CWM LLC)
103
Carson Wealth (CWM LLC)
Nebraska
$23K +$23.1K +120 New
MAM
104
Mystic Asset Management
Rhode Island
$20K +$20.6K +107 New
LWA
105
Lenox Wealth Advisors
New York
$19K – – –
M
106
MOTCO
Texas
$19K – – –
WT
107
Whittier Trust
California
$19K – – –
FP
108
Financial Perspectives
Minnesota
$16.7K – – –
ADL
109
Asset Dedication LLC
California
$16K – – –
CAPTRUST Financial Advisors
110
CAPTRUST Financial Advisors
North Carolina
$15K – – –
CFA
111
Carroll Financial Associates
North Carolina
$14K – – –
NFG
112
Next Financial Group
Texas
$14K – – –
National Bank of Canada
113
National Bank of Canada
Quebec, Canada
$14K +$14.5K +75 New
Citigroup
114
Citigroup
New York
$10K – – –
AA
115
Ancora Advisors
Ohio
$9K – – –
SWM
116
Spire Wealth Management
Virginia
$9K – – –
AHIA
117
Andrew Hill Investment Advisors
Florida
$9K +$9.64K +50 New
GFPC
118
Global Financial Private Client
Florida
$8.33K – – –
CA
119
CoreCap Advisors
Michigan
$5K +$5.01K +26 New
PP
120
Pacifica Partners
Canada
$4K – – –
VanEck Associates
121
VanEck Associates
New York
$4K +$3.66K +19 New
AIP
122
Ameritas Investment Partners
Nebraska
$3K – – –
VRM
123
Vectors Research Management
New York
$3K – – –
CB
124
CNB Bank
Pennsylvania
$3K +$3.47K +18 New
BHWM
125
Beaird Harris Wealth Management
Texas
$1K +$1.35K +7 New
2 3 4
5
6

BBH Hedge Fund Activity: Q4 2021 in Review

126 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q4 2021, worth a combined $171M — up 5.1% from $163M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new BBH positions and 12 closed out — a net gain of 9 holders — while 29 added to existing stakes and 33 trimmed.

The largest buyer was Bank of America, adding an estimated $17M. The largest seller was Stifel Financial, cutting an estimated $2.49M.

  • 126 institutional investors held VanEck Biotech ETF (BBH) as of Q4 2021, up from 118 in Q3 2021.
  • Funds reported $171M of VanEck Biotech ETF stock for Q4 2021, up 5.1% quarter-over-quarter.
  • 21 funds opened new VanEck Biotech ETF positions in Q4 2021 and 12 closed out, a net change of +9 holders.
  • The largest VanEck Biotech ETF buyer in Q4 2021 was Bank of America, an estimated $17M added.
  • The largest VanEck Biotech ETF seller in Q4 2021 was Stifel Financial, an estimated $2.49M sold.

Based on aggregated 13F filings for Q4 2021.